Institute for Hygiene, Medical Centre Cologne-Merheim, Köln, Germany.
Robert Koch Institute, Wernigerode, Germany.
J Hosp Infect. 2019 Mar;101(3):264-271. doi: 10.1016/j.jhin.2018.10.023. Epub 2018 Nov 5.
Vancomycin-resistant Enterococcus faecium (VRE) is emerging in German intensive care units (ICUs). On a 32-bed surgical ICU at a university hospital, increasing numbers of nosocomial cases occurred despite enforcement of hand hygiene and environmental disinfection.
To introduce universal octenidine-based bathing in order to reduce the burden of VRE.
Between January 2012 and March 2014, patients were screened for VRE on admission and twice weekly. Active surveillance was undertaken for VRE infections and colonizations, and for bloodstream infections (BSI) with any pathogen. Intervention in this before-after study comprised of standardized octenidine-based bathing. Distinct subgroups of VRE colonizations or infections were defined and used for statistical analysis of frequency, prevalence and incidence density.
In the pre-intervention period (January 2012 to April 2013), the admission prevalence of VRE was 4/100 patients and the mean incidence density of nosocomial cases was 7.55/1000 patient-days (PD). Pulsed-field gel electrophoresis analysis revealed prevalence of three vanA and two vanB clusters. In the post-intervention period (August 2013 to March 2014), the admission prevalence of VRE was 2.41/100 patients and the mean incidence density of nosocomial cases was 2.61/1000 PD [P = 0.001 (pre- vs post-intervention)]. Thirteen nosocomial VRE infections were identified in the pre-intervention period, compared with one nosocomial VRE infection in the post-intervention period. Incidence densities of BSI pre- and post-intervention were 2.98 and 2.06/1000 PD (P = 0.15), respectively.
The epidemiology of emerging VRE appeared as a complex mix of admitted cases and transmissions in small clusters, challenging infection control measures. The implementation of universal octenidine-based bathing combined with a standardized washing regime led to a significant reduction in nosocomial VRE.
耐万古霉素粪肠球菌(VRE)在德国重症监护病房(ICU)中不断出现。在一家大学医院的 32 张床位的外科 ICU 中,尽管实施了手部卫生和环境消毒措施,但仍不断发生医院获得性病例。
引入通用的奥替尼啶沐浴,以降低 VRE 的负担。
在 2012 年 1 月至 2014 年 3 月期间,对入院患者和每周两次进行 VRE 筛查。对 VRE 感染和定植以及任何病原体引起的血流感染(BSI)进行主动监测。在这项前后对照研究中,干预措施包括标准化的奥替尼啶沐浴。对 VRE 定植或感染的不同亚组进行了定义,并用于频率、患病率和发病率密度的统计分析。
在干预前阶段(2012 年 1 月至 2013 年 4 月),VRE 的入院患病率为 4/100 名患者,医院获得性病例的平均发病率密度为 7.55/1000 患者日(PD)。脉冲场凝胶电泳分析显示,有三个 vanA 和两个 vanB 簇的流行率。在干预后阶段(2013 年 8 月至 2014 年 3 月),VRE 的入院患病率为 2.41/100 名患者,医院获得性病例的平均发病率密度为 2.61/1000 PD[P=0.001(干预前 vs 干预后)]。在干预前阶段,共发现 13 例医院获得性 VRE 感染,而在干预后阶段,仅发现 1 例医院获得性 VRE 感染。干预前后 BSI 的发病率密度分别为 2.98 和 2.06/1000 PD(P=0.15)。
新兴 VRE 的流行病学表现为混合了入院病例和小集群传播,这对感染控制措施提出了挑战。实施通用的奥替尼啶沐浴并结合标准化的洗涤方案,显著降低了医院获得性 VRE 的发生。